Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell diseaseMyrthe J. van Dijk, Richard van Wijk, Cleo Derichs et al.|HemaSphere|2024Cited by 14
P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMESJonathan de Wilde, Minke A.E. Rab, Titine Ruiter et al.|HemaSphere|2023Cited by 2
A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell diseaseMyrthe J. van Dijk, Minke A.E. Rab, Richard van Wijk et al.|eJHaem|2024Cited by 1